| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701492 | Journal of Thoracic Oncology | 2017 | 33 Pages |
Abstract
Conventionally fractionated radiotherapy in combination with anti-PD-L1 antibody shows a synergistic antitumor immunity in NSCLC. Furthermore, PD-L1 expression may be a significant clinical predictive factor for treatment response to radiotherapy in NSCLC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Xiaomei MD, PhD, Xuefei PhD, Tao MD, Huikang MD, Zhengfei MD, PhD, Fei MD, Caicun MD, PhD,